The effect of different doses of bolus dexmedetomidine to create controlled hypotension and the incidence of bradycardia in rhinoplasty surgery.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191110045388N1

Enrollment

Registered

2020-04-29

Start date

2019-09-22

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty. Other and unspecified disorders of nose and nasal sinuses

Interventions

Intervention 1: Intervention group: In the first group, dexmedetomidine is injected at a dose of 1 µ/kg within 10 minutes after induction of anesthesia according to the required standards. Dexmedeto

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with ASA1 and ASA2 Anesthesia score. The average age between 18 and 50 years.

Exclusion criteria

Exclusion criteria: Patient dissatisfaction with participating in the study Not having blood pressure

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: During Surgery. Method of measurement: Barometer.;Heart Rate. Timepoint: During Surgery. Method of measurement: Pulse Oximeter.	—

Secondary

Measure	Time frame
Bleeding during surgery. Timepoint: During Surgery. Method of measurement: Blood volume measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoudabeh Djalali Motlagh

Iran University of Medical Sciences

djalalimotlagh@icloud.com+98 21 8214 1360

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026